Brain Tumor Meeting 2019 - Berlin
Recently, we attanded the Brain Tumor Meeting held in Berlin at The Max Delbrück Center for Molecular Medicine. The group had the opportunity to present oral and poster presentations. This gave us opportunity to dissaminate and showcase our research.
Following projects were presented at the meeting:
Bożena Kamińska - 'Development of synthetic peptides targeting glioma-microglia interaction as a new therapeutics.'
Iwona Ciechomska - 'EGFR/FOXO3A/BIM signalling pathway determines chemosensitivity of BMP4-differentiated glioma stem-like cells to temozolomide.'
Aleksandra Ellert-Miklaszewska - 'Expression and function of NFAT (Nuclear Factor of Activated T cells) trancription factors in human gliomas.'
Agnieszka Kaczmarczyk - 'Noverl mutations in the RECQL4 gene contribute to the glioma pathogenesis.'
Sylwia K Król - 'Effects of helicase RECQL4 depletion of human glioma biology and chemosensitivity.'
Maria Pasierbińska - 'Blocking Osteopontin signalling inhibits glioma invasivness ad reduces tumor growth of intracranial human glioma in Nude mice.'
Katarzyna Poleszak - 'The role of tumor-derived Granulocyte Macrophage Colony Stimulating Factor (GM-CSF/CSF2) in regulation of microglia-dependent invasion in gliomas.'
Paweł Segit - 'Single-cell RNA-seq of glioma associated microglia and macrophages reveals cell type-specific and sex-specific differences.'
Kacper A Walentynowicz - 'Dissecting tumor associated microglia/macrophages responses in preclinical model of glioblastoma.'
Kamil Wojnicki - 'New insights into the role of BLM helicase in malignant gliomas.'